Evidence map›Paper›PMID 21768350›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Serine protease autotransporters from Shigella flexneri and pathogenic Escherichia coli target a broad range of leukocyte glycoproteins.

Fernando Ruiz-Perez, Rezwanul Wahid, Christina S Faherty, Krishnan Kolappaswamy, Liliana Rodriguez, Araceli Santiago, Ebony Murphy, Alan Cross, Marcelo B Sztein, James P Nataro

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 108 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. SPATEs promote the survival ofProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Oman medical journal · 2023
    Review
  11. The Diversity ofMicroorganisms · 2023
    Review
  12. Porcine extraintestinal pathogenicFrontiers in cellular and infection microbiology · 2023
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. EnterotoxigenicInfection and immunity · 2022
    Article
  18. Extraintestinal PathogenicPathogens (Basel, Switzerland) · 2021
    Review
  19. Recent Progress inPathogens (Basel, Switzerland) · 2021
    Review
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Fernando Ruiz-PerezCenter for Vaccine Development and Program of Comparative Medicine, Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA. fr3d@hscmail.mcc.virginia.edu
Rezwanul Wahid
Christina S Faherty
Krishnan Kolappaswamy
Liliana Rodriguez
Araceli Santiago
Ebony Murphy
Alan Cross
Marcelo B Sztein
James P Nataro
Institut de Recherche Vaccinale · FRUniversity of Maryland, Baltimore · USUniversity of Virginia · US

Funding

Virulence in Enteroaggregative Escherichia coliR01AI033096 · NIAID · UNIVERSITY OF VIRGINIA · PI NATARO, JAMES P. · 1996 to 2014
$6.6M
AUTOTRANSPORTERS OF ENTEROBACTERIACEAER01AI043615 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI NATARO, JAMES P. · 1999 to 2003
$1.4M
Autotransporters of enterobacteriaceaeR56AI043615 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI NATARO, JAMES P. · 2008 to 2008
$418k
ADHERENCE IN ENTEROAGGREGATIVE E. COLIR29AI033096 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI NATARO, JAMES P. · 1992 to 1996
–
NIAID NIH HHS AI-33096NIAID NIH HHS AI-43615NIAID NIH HHS R01 AI033096NIAID NIH HHS R01 AI043615NIAID NIH HHS R56 AI043615
6 · The paper itself

Abstract

The serine protease autotransporters of Enterobacteriaceae (SPATEs) are secreted by pathogenic Gram-negative bacteria through the autotransporter pathway. We previously classified SPATE proteins into two classes: cytotoxic (class 1) and noncytotoxic (class 2). Here, we show that Pic, a class 2 SPATE protein produced by Shigella flexneri 2a, uropathogenic and enteroaggregative Escherichia coli strains, targets a broad range of human leukocyte adhesion proteins. Substrate specificity was restricted to glycoproteins rich in O-linked glycans, including CD43, CD44, CD45, CD93, CD162 (PSGL-1; P-selectin glycoprotein ligand 1), and the surface-attached chemokine fractalkine, all implicated in leukocyte trafficking, migration, and inflammation. N-terminal sequencing of proteolytic products revealed Pic (protease involved in colonization) cleavage sites to occur before Thr or Ser residues. The purified carbohydrate sLewis-X implied in inflammation and malignancy inhibited cleavage of PSGL-1 by Pic. Exposure of human leukocytes to purified Pic resulted in polymorphonuclear cell activation, but impaired chemotaxis and transmigration; Pic-treated T cells underwent programmed cell death. We also show that the Pic-related protease Tsh/Hbp, implicated in extraintestinal infections, exhibited a spectrum of substrates similar to those cleaved by Pic. In the guinea pig keratoconjunctivitis model, a Shigella pic mutant induced greater inflammation than its parent strain. We suggest that the class-2 SPATEs represent unique immune-modulating bacterial virulence factors.

Indexed as

AnimalsBacterial ProteinsBinding SitesCell MovementChemokine CX3CL1Electrophoresis, Polyacrylamide GelEscherichia coliFlow CytometryGlycoproteinsGuinea PigsHost-Pathogen InteractionsHumansHyaluronan ReceptorsKeratoconjunctivitisLeukocyte Common AntigensLeukocytesBacterial ProteinsChemokine CX3CL1complement 1q receptorGlycoproteinsHyaluronan ReceptorsLeukocyte Common AntigensLeukosialinMembrane GlycoproteinsPic protein, Shigella flexneriP-selectin ligand proteinReceptors, ComplementSerine Proteases

Identifiers

PMID21768350
PMCPMC3150873
OpenAlexW2122730022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.